Charles River Laboratories International Inc

詳細情報 Charles River Laboratories International Inc 企業名

Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.

企業情報

企業コードCRL

会社名Charles River Laboratories International Inc

上場日Jun 23, 2000

設立日1994

最高経営責任者「CEO」Mr James C. Foster

従業員数18600

証券種類Ordinary Share

決算期末Jun 23

本社所在地251 Ballardvale St

都市WILMINGTON

証券取引所NYSE Consolidated

国United States of America

郵便番号01887

電話番号17812226000

ウェブサイトhttps://www.criver.com/

企業コードCRL

上場日Jun 23, 2000

設立日1994

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr James C. Foster

Chairman of the Board, President, Chief Executive Officer

267.96K

+6.88%

Ms. Birgit Girshick

Chief Operating Officer, Corporate Executive Vice President

57.72K

+24.38%

Ms. Victoria L. (Vicky) Creamer

Corporate Executive Vice President, Chief People Officer

17.89K

+48.67%

Mr. Joseph W. LaPlume

Corporate Executive Vice President - Corporate Development and Strategy

13.68K

-2.74%

Ms. Shannon M. Parisotto

Corporate Executive Vice President - Discovery and Safety Assessment Management

12.88K

+69.56%

Ms. Virginia M. (Gina) Wilson, CPA

Independent Director

4.91K

+23.86%

Dr. Nancy C. Andrews, M.D., Ph.D.

Independent Director

3.96K

+31.35%

Ms. Reshema Kemps-Polanco

Independent Director

2.59K

+155.42%

Dr. Craig B. Thompson, M.D.

Independent Director

2.41K

+64.49%

Mr. Abraham N. (Abe) Ceesay

Independent Director

946.00

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr James C. Foster

Chairman of the Board, President, Chief Executive Officer

267.96K

+6.88%

Ms. Birgit Girshick

Chief Operating Officer, Corporate Executive Vice President

57.72K

+24.38%

Ms. Victoria L. (Vicky) Creamer

Corporate Executive Vice President, Chief People Officer

17.89K

+48.67%

Mr. Joseph W. LaPlume

Corporate Executive Vice President - Corporate Development and Strategy

13.68K

-2.74%

Ms. Shannon M. Parisotto

Corporate Executive Vice President - Discovery and Safety Assessment Management

12.88K

+69.56%

Ms. Virginia M. (Gina) Wilson, CPA

Independent Director

4.91K

+23.86%

収益内訳

通貨: USD更新時刻: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

事業別USD

会社名

収益

比率

DSA

2.45B

60.53%

RMS

829.38M

20.48%

Manufacturing

769.33M

19.00%

地域別USD

会社名

収益

比率

United States

2.24B

55.31%

Europe

1.08B

26.62%

Canada

482.09M

11.90%

Asia Pacific (Region)

196.95M

4.86%

Other

52.82M

1.30%

事業別

地域別

事業別USD

会社名

収益

比率

DSA

2.45B

60.53%

RMS

829.38M

20.48%

Manufacturing

769.33M

19.00%

株主

更新時刻: Sat, May 17

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

12.41%

Wellington Management Company, LLP

8.72%

BlackRock Institutional Trust Company, N.A.

5.92%

UBS Financial Services, Inc.

4.86%

Kayne Anderson Rudnick Investment Management, LLC

3.97%

Other

64.11%

株主統計

比率

The Vanguard Group, Inc.

12.41%

Wellington Management Company, LLP

8.72%

BlackRock Institutional Trust Company, N.A.

5.92%

UBS Financial Services, Inc.

4.86%

Kayne Anderson Rudnick Investment Management, LLC

3.97%

Other

64.11%

種類

株主統計

比率

Investment Advisor/Hedge Fund

51.53%

Investment Advisor

39.65%

Hedge Fund

7.75%

Research Firm

7.70%

Pension Fund

1.84%

Bank and Trust

1.53%

Sovereign Wealth Fund

1.10%

Individual Investor

1.05%

Insurance Company

0.08%

機関投資家保有株

更新時刻: Mon, Jan 20

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q1

1407

54.59M

111.11%

-3.65M

2024Q4

1423

54.85M

107.26%

-4.35M

2024Q3

1392

53.78M

105.14%

-5.12M

2024Q2

1399

54.00M

104.84%

-4.00M

2024Q1

1393

53.76M

104.37%

-4.04M

2023Q4

1424

53.56M

104.42%

-4.24M

2023Q3

1446

53.56M

104.42%

-3.98M

2023Q2

1427

52.88M

103.32%

-3.95M

2023Q1

1431

52.72M

103.01%

-2.79M

2022Q4

1416

51.28M

100.65%

-3.46M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

6.13M

12.49%

+58.13K

+0.96%

Dec 31, 2024

Wellington Management Company, LLP

4.08M

8.3%

+335.66K

+8.97%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

2.95M

6.01%

-51.78K

-1.72%

Dec 31, 2024

Kayne Anderson Rudnick Investment Management, LLC

1.81M

3.68%

-134.28K

-6.92%

Dec 31, 2024

State Street Global Advisors (US)

2.18M

4.44%

+51.15K

+2.40%

Dec 31, 2024

Allspring Global Investments, LLC

1.81M

3.68%

+47.22K

+2.68%

Dec 31, 2024

Geode Capital Management, L.L.C.

1.23M

2.51%

+14.79K

+1.21%

Dec 31, 2024

Impactive Capital LP

1.20M

2.45%

+825.95K

+219.44%

Dec 31, 2024

Ariel Investments, LLC

1.07M

2.17%

+169.64K

+18.90%

Dec 31, 2024

詳細を見る

150.210USD

Charles River Laboratories International Inc

150.210

概要

企業名